480 Biomedical, Inc., a company focused on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery, has recently renewed its lease for its 27,311 s/f laboratory facility at 480 Arsenal St.
Colliers International's suburban brokerage team of Tucker Hansen and Joe Flaherty represented 480 Biomedical in negotiations with the landlord, Alexandria Real Estate Equities, Inc.
480 Arsenal St. is a two-story, 141,000 s/f laboratory building. The property is located five miles from I-90, and is close to the Arsenal Mall.
Major tenants of the building include New England Sports Network, Selecta Pharmaceuticals, and Dicerna Pharmaceuticals.